However, the top specialists at Blue Fin Vision employ various approaches that may benefit certain patients: Acute Management: Immediate discontinuation of GLP-1 medication when NAION is confirmed Corticosteroid therapy in selected cases Comprehensive cardiovascular risk factor assessment Secondary Prevention: Aggressive management of vascular risk factors Blood pressure optimisation Aspirin therapy consideration Regular monitoring of the unaffected eye Risk Factors and Patient Selection Certain patient populations require particularly careful consideration before initiating GLP-1 therapy: High-Risk Patients: Individuals with pre-existing diabetic retinopathy Patients with poorly controlled diabetes and high HbA1c levels Those with cardiovascular risk factors Elderly patients Individuals with optic nerve head abnormalities The experienced team at Blue Fin Vision collaborates closely with endocrinologists and primary care physicians to ensure appropriate patient selection and monitoring protocols

Lichty JJ, Malecki JL, Agnew HD, et al
doi: 10.2337/dc15-2727 277 HardingJJGaneaE
Always look at the patient information leaflet for any extra directions that fit your treatment and what your doctor wants for you
Adverse reactions to Semaglutide reported include but are not limited to: Gastrointestinal Issues: The most commonly reported adverse reactions to Semaglutide include nausea , vomiting , diarrhea , abdominal pain , and constipation
The time is now to get healthy, and we can't wait to help you on this path to a new you